Karakteristik Pasien Non-Small Cell Lung Carcinoma Di RSUD Abdoel Wahab Sjahranie Samarinda

Andi Muhammad Almer Alfarisyi, Nurul Hasanah, Emil Bachtiar Moerad

Sari


Kanker paru merupakan kanker penyebab kematian tertinggi di dunia. Non-small cell lung carcinoma (NSCLC) adalah tipe kanker paru terbanyak yang terbagi menjadi tiga subtipe. Berdasarkan gambaran patologi anatominya dibagi menjadi adenokarsinoma, squamous cell carcinoma (SCC), dan large cell carcinoma. Penelitian ini bertujuan untuk mengetahui karakteristik pasien NSCLC di RSUD Abdoel Wahab Sjahranie Samarinda tahun 2023 berdasarkan jenis kelamin, usia, indeks massa tubuh (IMT), riwayat penyakit paru, keluhan utama, subtipe patologi anatomi dan stadium. Penelitian ini merupakan penelitian deskriptif observasional dengan pendekatan cross sectional. Penelitian ini menggunakan total sampling pasien yang didiagnosis NSCLC di RSUD Abdoel Wahab Sjahranie Samarinda tahun 2023. Dari 133 data pasien NSCLC didapatkan mayoritas jenis kelamin laki-laki (69,9%), kelompok usia 40-59 tahun (52,6%), IMT normal (55,6%), riwayat penyakit tuberkulosis (9%) dan tidak memiliki riwayat penyakit paru (86,5%), keluhan utama sesak napas (36,8%), ukuran nodul berdasarkan gambaran CT scan >30 mm (72,9%), subtipe patologi anatomi adenokarsinoma (53,4%) dan stadium IVA (25,6%). Disimpulkan pada penelitian bahwa mayoritas pasien NSCLC merupakan laki-laki, kelompok usia 40-59 tahun, IMT normal, tidak memiliki riwayat penyakit paru, keluhan utama sesak napas, ukuran nodul >30mm, dan stadium IVA.


Kata Kunci


Non-small cell lung carcinoma (NSCLC); Karakteristik; Adenokarsinoma; CT scan

Teks Lengkap:

PDF

Referensi


Advani, S., Zhang, D., Tammemagi, M., Akinyemiju, T., Gould, M. K., Silvestri, G. A., & Braithwaite, D. (2021). Comorbidity profiles and lung cancer screening among older adults. Annals of the American Thoracic Society, 18(11), 1889–1893. https://doi.org/10.1513/AnnalsATS.202010-1276OC

Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging . CA: A Cancer Journal for Clinicians, 67(2), 93–99. https://doi.org/10.3322/caac.21388

Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019). Global epidemiology of lung cancer. In Annals of Global Health (Vol. 85, Issue 1). Ubiquity Press. https://doi.org/10.5334/aogh.2419

Bhowmik, S., Mohanto, N. C., Sarker, D., & Sorove, A. A. (2022). Incidence and Risk of Lung Cancer in Tuberculosis Patients, and Vice Versa: A Literature Review of the Last Decade. BioMed Research International, 2022. https://doi.org/10.1155/2022/1702819

Chen, Y. M., Lai, C. H., Lin, C. Y., Tsai, Y. H., Chang, Y. C., Chen, H. C., Tseng, C. C., Chang, H. C., Huang, K. T., Chen, Y. C., Fang, W. F., Wang, C. C., Chao, T. Y., & Lin, M. C. (2021). Body mass index, weight loss, and mortality risk in advanced-stage non-small cell lung cancer patients: A focus on egfr mutation. Nutrients, 13(11). https://doi.org/10.3390/nu13113761

Cukic, V. (2017). The Association Between Lung Carcinoma and Tuberculosis. Medical Archives (Sarajevo, Bosnia and Herzegovina), 71(3), 212–214. https://doi.org/10.5455/medarh.2017.71.212-214

Department of Health, U. S., & Services, H. (2014). The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. www.cdc.gov/tobacco

Din Shah, N. U., Ali, M. N., Ganai, B. A., Mudassar, S., Khan, M. S., Kour, J., Waza, A. A., Rasool, M. T., & Lone, A. M. (2020). Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India). Heliyon, 6(2). https://doi.org/10.1016/j.heliyon.2020.e03488

Ganti, A. K., Klein, A. B., Cotarla, I., Seal, B., & Chou, E. (2021). Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients with Non-Small Cell Lung Cancer in the US. JAMA Oncology, 7(12), 1824–1832. https://doi.org/10.1001/jamaoncol.2021.4932

Hamilton, W., Peters, T. J., Round, A., & Sharp, D. (2005). What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax, 60(12), 1059–1065. https://doi.org/10.1136/thx.2005.045880

Henschke, C. I., Yip, R., Smith, J. P., Wolf, A. S., Flores, R. M., Liang, M., Salvatore, M. M., Liu, Y., Xu, D. M., & Yankelevitz, D. F. (2016). CT screening for lung cancer: Part-solid nodules in baseline and annual repeat rounds. American Journal of Roentgenology, 207(6), 1176–

https://doi.org/10.2214/AJR.16.16043

Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F. C., Marongiu, F., Evans, E. J., Moore, D. A., Rodrigues, F. S., Pich, O., Bakker, B., Cha, H., Myers, R., van Maldegem, F., Boumelha,

J., Veeriah, S., Rowan, A., … Swanton, C. (2023). Lung adenocarcinoma promotion by air pollutants. Nature, 616(7955), 159–167. https://doi.org/10.1038/s41586-023-05874-3

Hong, S., Mok, Y., Jeon, C., Jee, S. H., & Samet, J. M. (2016a). Tuberculosis, smoking and risk for lung cancer incidence and mortality. International Journal of Cancer, 139(11), 2447–2455. https://doi.org/10.1002/ijc.30384

Hong, S., Mok, Y., Jeon, C., Jee, S. H., & Samet, J. M. (2016b). Tuberculosis, smoking and risk for lung cancer incidence and mortality. International Journal of Cancer, 139(11), 2447–2455. https://doi.org/10.1002/ijc.30384

Jung, H. A., Lee, D. H., Lim, S. M., Yu, H., Yoon, S., Kim, D. K., Kim, K. P., Jeong, H., Doh, H., Lim, S., Kim, J., Zhao, X., Horsburgh, D., Patel, D., Kim, J. A., & Toh, K. C. (2024). Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea. JAMA Network Open, 7(2), E2355331. https://doi.org/10.1001/jamanetworkopen.2023.55331

Kasper, D. L., Fauci, A. S., Hauser, S. L., Longo, D. L., Jameson, J. L., & Loscalzo, J. (2018). Harrison’s Principles of Internal Medicine 20/E (Vol.1 & Vol.2) (ebook) (20th ed., Vol. 1). McGraw Hill Professional.

Kocher, F., Lunger, F., Seeber, A., Amann, A., Pircher, A., Hilbe, W., &

Fiegl, M. (2016). Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis. Clinical Lung Cancer, 17(1), 62-67.e1. https://doi.org/10.1016/j.cllc.2015.08.006

Koswara, T., Iriawan, J., & Surya, F. (2022). Karakteristik Karsinoma Paru Bukan Sel Kecil Dan Hasil Pemeriksaan EGFR Di RSUP DR. Hasan Sadikin Periode Tahun 2018-2020. Medika Kartika: Jurnal Kedokteran Dan Kesehatan, 5.

Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., Zhang, Z., Gao, T., Zhang, Y., & Li, L. (2023). Global burden and trends of lung cancer incidence and mortality. Chinese Medical Journal, 136(13), 1583–1590. https://doi.org/10.1097/CM9.0000000000002529

Liang, X., Gao, X., Wang, F., Li, S., Zhou, Y., Guo, P., Meng, Y., & Lu, T. (2023). Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer. Cancer Medicine, 12(13), 14171–14182. https://doi.org/10.1002/cam4.6083

Meynard, C., Mansuet-Lupo, A., Giraud, N., Boulle, G., Imbault, P., Guénégou-Arnoux, A., Bobbio, A., Durdux, C., Damotte, D., & Giraud, P. (2021). Size and Predictive Factors of Microscopic Tumor Extension in Locally Advanced Non-Small Cell Lung Cancer. Practical Radiation Oncology: An official journal of the American Society for Radiation Oncology. An Official Journal of the American Society for Radiation Oncology, 6. https://doi.org/10.1016/j.prro.2021.05.006ï

Oh, C. M., Lee, S., Kwon, H., Hwangbo, B., & Cho, H. (2023). Prevalence of pre-existing lung diseases and their association with income level among patients with lung cancer: a nationwide population-based case-control study in South Korea. BMJ Open Respiratory Research, 10(1). https://doi.org/10.1136/bmjresp-2023-001772

Otoshi, R., Ikeda, S., Kaneko, T., Sagawa, S., Yamada, C., Kumagai, K., Moriuchi, A., Sekine, A., Baba, T., & Ogura, T. (2024). Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis. In Cancers (Vol. 16, Issue 9). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cancers16091734

Qi, C., Sun, S. W., & Xiong, X. Z. (2022). From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. In International Journal of COPD (Vol. 17, pp. 2603–2621). Dove Medical Press Ltd. https://doi.org/10.2147/COPD.S380732

Razi, M. F., Studi, P., Ilmu, P., & Sosial, P. (2022). Dampak Aktivitas Pertambangan Batubara Terhadap Lingkungan dan Masyarakat Kalimantan Timur. https://doi.org/https://doi.org/10.31219/osf.io/ea65p

Ruano-Raviña, A., Provencio, M., Calvo De Juan, V., Carcereny, E., Moran, T., Rodriguez-Abreu, D., López-Castro, R., Cuadrado Albite, E., Guirado, M., Gómez González, L., Massutí, B., Ortega Granados, A. L., Blasco, A., Cobo, M., Garcia-Campelo, R., Bosch, J., Trigo, J., Juan, Ó., Aguado De La Rosa, C., … Cerezo, S. (2020). Lung cancer symptoms at diagnosis: Results of a nationwide registry study. ESMO Open, 5(6). https://doi.org/10.1136/esmoopen-2020-001021

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48. https://doi.org/10.3322/caac.21763

Tateishi, A., Horinouchi, H., Yoshida, T., Masuda, K., Jo, H., Shinno, Y., Okuma, Y., Goto, Y., Yamamoto, N., & Ohe, Y. (2022). Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancer. Respiratory Investigation, 60(2), 234–240. https://doi.org/10.1016/j.resinv.2021.11.003

Tian, Y., Xu, L., Li, X., Li, H., & Zhao, M. (2023). SMARCA4: Current status and future perspectives in non-small-cell lung cancer. In Cancer Letters (Vol. 554). Elsevier Ireland Ltd. https://doi.org/10.1016/j.canlet.2022.216022

WHO. (2021). WHO Classification of Tumours Editorial Board. Thoracic tumours (Vol. 5).

WHO: Regional Office for Europe. (2020). World Cancer Report: cancer research for cancer prevention. IARC.

You, D., Wang, D., Wu, Y., Chen, X., Shao, F., Wei, Y., Zhang, R., Lange, T., Ma, H., Xu, H., Hu, Z., Christiani, D. C., Shen, H., Chen, F., & Zhao, Y. (2022). Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study. BMC Medicine, 20(1). https://doi.org/10.1186/s12916-022-02400-6

Yu, D., Zheng, W., Johansson, M., Lan, Q., Park, Y., White, E., Matthews, C. E., Sawada, N., Gao, Y. T., Robien, K., Sinha, R., Langhammer, A., Kaaks, R., Giovannucci, E. L., Liao, L. M., Xiang, Y. B., Lazovich, D. A., Peters, U., Zhang, X., … Shu, X. O. (2018). Overall and central obesity and risk of lung cancer: A pooled analysis. Journal of the National Cancer Institute, 110(8), 831–842. https://doi.org/10.1093/jnci/djx286

Zhang, Y.-L., Yuan, J.-Q., Wang, K.-F., Fu, X.-H., Han, X.-R., Threapleton, D., Yang, Z.-Y., Mao, C., & Tang, J.-L. (2016). The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. In Oncotarget (Vol. 7, Issue 48). www.impactjournals.com/oncotarget/




DOI: https://doi.org/10.33024/jikk.v12i5.19490

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.